Skip to Content
Merck
CN

BK virus in the kidney transplant patient.

The American journal of the medical sciences (2013-05-24)
Sarat Kuppachi, Beje Thomas, Kenneth E Kokko
ABSTRACT

BK virus, a member of the polyomavirus family, is a well-recognized cause of irreversible graft failure after kidney transplantation. Awareness of the relationship between BK infection and immunosuppression along with better understanding of its pathogenesis has contributed to increasing rates of its diagnosis. Current therapies are aimed at early diagnosis, limiting inflammation caused by the virus and elimination of the virus through different strategies. The epidemiology, pathogenesis and the different modalities of therapy available are discussed in this review along with the approach to retransplantation in the setting of graft failure from BK infection.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Leflunomide, Immunosuppressant
Leflunomide, European Pharmacopoeia (EP) Reference Standard
Leflunomide for peak identification, European Pharmacopoeia (EP) Reference Standard